Table 1.
Summary of clinical characteristics and laboratory data of vaccinated patients with hemoglobinopathies.
| Parameters | Values |
|---|---|
|
| |
| Age (years), Mean ± SD; Min-Max | 35.0 ± 8.5 (18–70) |
|
| |
| Sex (Male) (%) | 38 |
|
| |
| Median serum ferritin level (ng/mL); Range (min-max) | 968 (60–18000) |
|
| |
| Frequency of blood transfusions (N and %) | |
| Regular | 355(84.7) |
| Irregular | 7 (1.7) |
| No | 57 (13.6) |
|
| |
| Type transfusion (N and %) | |
| Leukoreduced red blood cells | 272 (62.7) |
| Leukofilter red blood cells | 34 (7.8) |
| Washed red blood cells | 28 (6.5) |
|
| |
| Synchronous blood transfusion and vaccination (N and %) | 8 (1.8) |
|
| |
| Splenectomy (yes) (N and %) | 216 (49.7) |
|
| |
| Hemoglobin level (g/dL); Mean ± SD – Min-Max | 9.8±1.1 (7.3–12.9) |
|
| |
| Comorbidities (N. and %) | |
| Hypogonadism | 177 (41) |
| Diabetes | 57 (13.1) |
| Hypothyroidism | 46 (10.6) |
| Pulmonary hypertension | 86 (20) |
| Chronic heart failure | 25 (5.8) |
| Chronic liver disease | 16 (3.7) |
|
| |
| SARS-CoV-2 infection after vaccination (N. and %) | 90 (20.7) |